Philips Appoints Jean Botti as Chief Innovation and Strategy Officer

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced the appointment of Jean Botti as Chief Innovation and Strategy Officer as part of the company's strategy to capture a larger portion of the HealthTech opportunities. Jean Botti, who will join Philips as of April 1, 2016 from Airbus Group (AIR), will become a member of Philips' Executive Committee and will report directly to Philips CEO Frans van Houten. Jean Botti will succeed Jim Andrew, who left Philips in the fourth quarter of 2015 for personal reasons.

"I am very pleased that Jean Botti has decided to join Philips on our journey to extending our leadership in health technology, capitalizing on opportunities arising from the consumerization and industrialization of healthcare to transform the delivery of care," said Frans van Houten. "Jean has had a remarkable and distinguished career and his achievements at Airbus are impressive, ranging from his ability to continually improve the company’s innovation capabilities and building intelligent systems, to embedding quality across the company’s value chain. His track record in driving innovation and change in high-tech industries will prove extremely valuable for Philips."

Jean Botti (French, 1957) joins Philips from Airbus Group, a global leader in aeronautics, space and related services, where he served as Chief Technical Officer since 2006. Prior to this, he worked in various roles in Europe and the U.S. at among others Renault and General Motors. He graduated from the National Institute of Applied Sciences (INSA) in Toulouse in 1986, with a degree in mechanical engineering. He holds a PhD in mechanical engineering from the Conservatoire des Arts et Métiers in collaboration with the University of Michigan. Jean Botti also earned an MBA from Central Michigan University and a degree in Research and Development Management from the Massachusetts Institute of Technology (MIT).

"I am excited to join a company that has made it its mission to improve the lives of billions of people every year globally and that has such a strong track record in innovation, advanced technologies and design capabilities," said Jean Botti. "I am convinced that my experience in the automotive and aviation industries in terms of digital transformation and process optimization will support Philips' ambitions to drive the personalization and industrialization of care."

The appointment of Jean Botti is the latest example of Philips' efforts to align its organization in order to better capitalize on HealthTech market opportunities.

Recently, and in addition to his role as CEO of Personal Health, Philips appointed Pieter Nota to the newly-created position of Chief Marketing Officer, whose role is to establish an integrated approach to marketing, building out Philips’ capabilities to drive marketing excellence in the rapidly changing world of health technology.

Furthermore, Philips established the Monitoring, Informatics & Connected Care segment, led by Jeroen Tas and comprising Patient Care & Monitoring Solutions, Healthcare Informatics, Emerging Businesses and a newly created Population Health Management business.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...